86 related articles for article (PubMed ID: 9493600)
1. Comparative studies of an orally-active factor Xa inhibitor, YM-60828, with other antithrombotic agents in a rat model of arterial thrombosis.
Kawasaki T; Sato K; Sakai Y; Hirayama F; Koshio H; Taniuchi Y; Matsumoto Y
Thromb Haemost; 1998 Feb; 79(2):410-6. PubMed ID: 9493600
[TBL] [Abstract][Full Text] [Related]
2. Effect of a synthetic factor Xa inhibitor, YM-60828, on blood vessel patency in combination with a thrombolytic agent and on blood loss from the operation site in a rat model of arterial thrombosis.
Kawasaki T; Sato K; Hirayama F; Koshio H; Taniuchi Y; Matsumoto Y
Thromb Haemost; 1998 Apr; 79(4):859-64. PubMed ID: 9569205
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time.
Sato K; Kawasaki T; Hisamichi N; Taniuchi Y; Hirayama F; Koshio H; Matsumoto Y
Br J Pharmacol; 1998 Jan; 123(1):92-6. PubMed ID: 9484858
[TBL] [Abstract][Full Text] [Related]
4. The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.
Cho JH; Yun CH; Seo HS; Koga T; Dan T; Koo BA; Kim HY
Thromb Haemost; 2001 Dec; 86(6):1512-20. PubMed ID: 11776321
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological characterization of YM-60828, a newly synthesized and orally active inhibitor of human factor Xa.
Taniuchi Y; Sakai Y; Hisamichi N; Kayama M; Mano Y; Sato K; Hirayama F; Koshio H; Matsumoto Y; Kawasaki T
Thromb Haemost; 1998 Mar; 79(3):543-8. PubMed ID: 9531037
[TBL] [Abstract][Full Text] [Related]
6. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic effects of YM-60828 in three thrombosis models in guinea pigs.
Sato K; Kawasaki T; Hisamichi N; Taniuchi Y; Hirayama F; Koshio H; Ichihara M; Matsumoto Y
Eur J Pharmacol; 1998 May; 350(1):87-91. PubMed ID: 9683019
[TBL] [Abstract][Full Text] [Related]
8. Cooperative antithrombotic effect from the simultaneous inhibition of thrombin and factor Xa.
Giardino EC; Haertlein BJ; de Garavilla L; Costanzo MJ; Damiano BP; Andrade-Gordon P; Maryanoff BE
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):128-34. PubMed ID: 20010091
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
Berry CN; Girard D; Lochot S; Lecoffre C
Br J Pharmacol; 1994 Dec; 113(4):1209-14. PubMed ID: 7889274
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis.
Heran C; Morgan S; Kasiewski C; Bostwick J; Bentley R; Klein S; Chu V; Brown K; Colussi D; Czekaj M; Perrone M; Leadley R
Eur J Pharmacol; 2000 Feb; 389(2-3):201-7. PubMed ID: 10688985
[TBL] [Abstract][Full Text] [Related]
11. YM-60828, a novel factor Xa inhibitor: separation of its antithrombotic effects from its prolongation of bleeding time.
Sato K; Kawasaki T; Taniuchi Y; Hirayama F; Koshio H; Matsumoto Y
Eur J Pharmacol; 1997 Nov; 339(2-3):141-6. PubMed ID: 9473127
[TBL] [Abstract][Full Text] [Related]
12. Effects of SanOrg123781A, a synthetic hexadecasaccharide, in a mouse model of electrically induced carotid artery injury: synergism with the antiplatelet agent clopidogrel.
Lorrain J; Lechaire I; Gauffeny C; Masson R; Roome N; Herault JP; O'Connor SE; Schaeffer P; Herbert JM
J Pharmacol Exp Ther; 2004 Apr; 309(1):235-40. PubMed ID: 14718579
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: comparison with a direct thrombin inhibitor and antithrombin III-dependent anticoagulants.
Morishima Y; Tanabe K; Terada Y; Hara T; Kunitada S
Thromb Haemost; 1997 Nov; 78(5):1366-71. PubMed ID: 9408021
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in rats.
Sato K; Taniuchi Y; Kawasaki T; Hirayama F; Koshio H; Matsumoto Y
Eur J Pharmacol; 1998 Apr; 347(2-3):231-6. PubMed ID: 9653887
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice.
Sato K; Taniuchi Y; Kawasaki T; Hirayama F; Koshio H; Matsumoto Y; Iizumi Y
Jpn J Pharmacol; 1998 Oct; 78(2):191-7. PubMed ID: 9829622
[TBL] [Abstract][Full Text] [Related]
16. Nonpeptide factor Xa inhibitors II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis.
Wong PC; Crain EJ; Knabb RM; Meade RP; Quan ML; Watson CA; Wexler RR; Wright MR; Slee AM
J Pharmacol Exp Ther; 2000 Oct; 295(1):212-8. PubMed ID: 10991981
[TBL] [Abstract][Full Text] [Related]
17. The discovery of YM-60828: a potent, selective and orally-bioavailable factor Xa inhibitor.
Hirayama F; Koshio H; Katayama N; Kurihara H; Taniuchi Y; Sato K; Hisamichi N; Sakai-Moritani Y; Kawasaki T; Matsumoto Y; Yanagisawa I
Bioorg Med Chem; 2002 May; 10(5):1509-23. PubMed ID: 11886813
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
Berry CN; Girard D; Girardot C; Lochot S; Lunven C; Visconte C
Semin Thromb Hemost; 1996; 22(3):233-41. PubMed ID: 8836007
[TBL] [Abstract][Full Text] [Related]
19. Orally administered heparins prevent arterial thrombosis in a rat model.
Pinel C; Wice SM; Hiebert LM
Thromb Haemost; 2004 May; 91(5):919-26. PubMed ID: 15116252
[TBL] [Abstract][Full Text] [Related]
20. Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosis.
Parry TJ; Huang Z; Chen C; Connelly MA; Perzborn E; Andrade-Gordon P; Damiano BP
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):720-6. PubMed ID: 21986468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
